Like a crazy-looking pair of glasses that makes even my worst motion sickness disappear.

It has been over 40 years since a new prescription drug has been FDA-approved for motion sickness. The last drug was a scopolamine patch (Transderm Scop®) worn behind the ear, and it was approved in ...

Nausea, pale skin, cold sweats, fatigue, increased heart rate – the whole experience can feel debilitating, especially when it strikes at the worst possible moment. But whether you’re struggling with ...

Sombr dug through Phoebe Bridgers’ emotional wreckage with a cover of “Motion Sickness” for BBC Radio 1. The 20-year-old crooned the melancholic record backed solely by a solemn piano melody. “It’s ...

In December, the U.S. Food and Drug Administration (FDA) approved Vanda Pharmaceuticals Inc.‘s (NASDAQ: VNDA) Nereus (tradipitant) to prevent vomiting induced by motion. The approval marks the first ...

Vanda Pharmaceuticals is buy-rated following FDA approval of Nereus for motion sickness, with shares offering upside into 2026 catalysts. VNDA's Q3 saw strong Fanapt sales growth, but higher R&D and ...

Vanda Pharmaceuticals, Inc. VNDA announced that the FDA has approved its candidate tradipitant for the prevention of vomiting induced by motion. The drug has been approved under the brand name Nereus.

Vanda Pharmaceuticals (VNDA) added ~21% in the premarket on Wednesday after the U.S. FDA approved its motion sickness therapy Nereus (tradipitant), developed in partnership with Eli Lilly (LLY).

WASHINGTON, Dec. 30, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has approved NEREUS™ (tradipitant), an oral ...

Experiencing motion sickness can be frustrating. You just want to appreciate the views on a long drive or enjoy a long-awaited trip on a cruise ship, but instead, you’re trying not to lose your lunch.